Opportunity ID: 332553

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-TR-21-015
Funding Opportunity Title: Intramural – Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.350 — National Center for Advancing Translational Sciences
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 02, 2021
Last Updated Date: Apr 02, 2021
Original Closing Date for Applications: Jun 28, 2021
Current Closing Date for Applications: Jun 28, 2021
Archive Date: Aug 03, 2021
Estimated Total Program Funding: $1,500,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Independent school districts
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
State governments
Native American tribal governments (Federally recognized)
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
City or township governments
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to promote partnerships between intramural investigators at the NCATS 3-D Bioprinting Laboratory and extramural researchers to jointly develop and demonstrate the use of 3-D biofabricated tissues for disease modeling and drug screening.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-21-015.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00266316 May 28, 2021 Jun 28, 2021 View

Package 1

Mandatory forms

332553 RR_SF424_2_0-2.0.pdf

332553 PHS398_CoverPageSupplement_5_0-5.0.pdf

332553 RR_OtherProjectInfo_1_4-1.4.pdf

332553 PerformanceSite_2_0-2.0.pdf

332553 RR_KeyPersonExpanded_2_0-2.0.pdf

332553 RR_Budget_1_4-1.4.pdf

332553 PHS398_ResearchPlan_4_0-4.0.pdf

332553 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

332553 RR_SubawardBudget30_1_4-1.4.pdf

332553 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T21:18:06-05:00

Share This Post, Choose Your Platform!

About the Author: